Trial Profile
Efficacy and safety of avandamet or uptitrated metformin treatment in patients with type 2 diabetes inadequately controlled with metformin alone
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Aug 2023
Price :
$35
*
At a glance
- Drugs Rosiglitazone/metformin (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 18 Nov 2013 New trial record